Hamlet BioPharma AB publ (STU:7ZT) Asset Impairment Charge : €0.00 Mil (TTM As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Hamlet BioPharma AB publ Asset Impairment Charge?

Hamlet BioPharma AB publ's Asset Impairment Charge for the three months ended in Sep. 2024 was €0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Sep. 2024 was €0.00 Mil.

Hamlet BioPharma AB publ Asset Impairment Charge Historical Data

The historical data trend for Hamlet BioPharma AB publ's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hamlet BioPharma AB publ Asset Impairment Charge Chart

Hamlet BioPharma AB publ Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Asset Impairment Charge

Get a 7-Day Free Trial

Hamlet BioPharma AB publ Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Asset Impairment Charge	Get a 7-Day Free Trial															-	-	-	-	-

Hamlet BioPharma AB publ Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

Hamlet BioPharma AB publ Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Hamlet BioPharma AB publ's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Hamlet BioPharma AB publ Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hamlet BioPharma AB publ (STU:7ZT) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

HAMLET B:Sweden

Address

Klinikgatan 32, BMC D10, Lund, SWE, SE-222 42

Website

http://www.hamletpharma.com

Hamlet BioPharma AB publ is a pharmaceutical company engaged in the research and development of drugs used for curing cancer.

Hamlet BioPharma AB publ Headlines

No Headlines